Effects of Chitosan on Chondrocytes Derived from Human Nasal Septal Cartilage.
Abstract
[BACKGROUND/AIM] The aim of this study was to evaluate the influence of chitosan on the growth of nasal septal chondrocytes (NSCs). The final goal was to establish a novel methodology to enhance nasal septal cartilage regeneration.
[MATERIALS AND METHODS] Human NSCs were isolated and their morphology was examined using Alcian blue staining and observed by light microscopy. The isolated NSCs were grown with various concentrations of chitosan and the expression of COL2A1 was investigated.
[RESULTS] NSCs were successfully isolated from nasal septal cartilage. Co-culture with 0.2% of chitosan greatly enhanced proliferation of NSCs compared to control cells. However, 0.5% of chitosan was harmful to NSCs, resulting in cell detachment from the culture plate. Furthermore, the addition of 0.2% chitosan significantly improved the expression of COL2A1 in NSCs.
[CONCLUSION] To our knowledge, this is the first report to demonstrate that chitosan could effectively guide the attachment and growth of human NSCs. Chitosan appears to be a promising additive for NSC culture, which sets the stage for studying tissue regeneration in nasal septal cartilage deficiency, rhinoplasty, and craniofacial reconstruction.
[MATERIALS AND METHODS] Human NSCs were isolated and their morphology was examined using Alcian blue staining and observed by light microscopy. The isolated NSCs were grown with various concentrations of chitosan and the expression of COL2A1 was investigated.
[RESULTS] NSCs were successfully isolated from nasal septal cartilage. Co-culture with 0.2% of chitosan greatly enhanced proliferation of NSCs compared to control cells. However, 0.5% of chitosan was harmful to NSCs, resulting in cell detachment from the culture plate. Furthermore, the addition of 0.2% chitosan significantly improved the expression of COL2A1 in NSCs.
[CONCLUSION] To our knowledge, this is the first report to demonstrate that chitosan could effectively guide the attachment and growth of human NSCs. Chitosan appears to be a promising additive for NSC culture, which sets the stage for studying tissue regeneration in nasal septal cartilage deficiency, rhinoplasty, and craniofacial reconstruction.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 재료 | septal cartilage
|
비중격연골 | dict | 4 | |
| 시술 | rhinoplasty
|
코성형술 | dict | 1 | |
| 해부 | Chondrocytes
|
scispacy | 1 | ||
| 해부 | NSCs
→ nasal septal chondrocytes
|
scispacy | 1 | ||
| 해부 | cartilage
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | NSC
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | craniofacial
|
scispacy | 1 | ||
| 합병증 | nasal septal
|
scispacy | 1 | ||
| 약물 | Chitosan
|
C0162969
chitosan
|
scispacy | 1 | |
| 약물 | Alcian blue
|
C0001933
Alcian Blue
|
scispacy | 1 | |
| 약물 | NSC
|
C4479344
SCLEROSING CHOLANGITIS, NEONATAL
|
scispacy | 1 | |
| 약물 | Alcian
|
scispacy | 1 | ||
| 질환 | nasal septal cartilage
|
C0225420
Septal Nasal Cartilage
|
scispacy | 1 | |
| 질환 | nasal septal cartilage deficiency
|
scispacy | 1 | ||
| 기타 | Human Nasal Septal Cartilage
|
scispacy | 1 | ||
| 기타 | nasal septal
|
scispacy | 1 | ||
| 기타 | Human NSCs
|
scispacy | 1 | ||
| 기타 | COL2A1
|
scispacy | 1 |
MeSH Terms
Humans; Chondrocytes; Chitosan; Cells, Cultured; Tissue Engineering; Cartilage; Tissue Scaffolds
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (2)
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Aesthetically ideal noses created using a single artificial intelligence model: Validating literature and exploring ethnic differences.
- Septocolumellar strut technique: Tip stability and aesthetic outcomes in rhinoplasty.
- Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.
- Factors on Quality of Life Improvement in Septorhinoplasty: Prospective Evaluation Using the Functional Rhinoplasty Outcome Inventory 17 and Its Minimally Important Difference.